Guia Clínica de l'HIV 2003 - Sida Studi

PODZ.QXD 4/03/03 06:30 Página 127– Miralles, P., Rubio, C., Berenguer, J. i cols. Recomendaciones de GESIDA/PETHEMAsobre diagnóstico y tratamiento de los linfomas en pacientes infectados por elvirus de la inmunodeficiencia humana. Med Clín (Barc) 2002; 118; 225-236.– Navarro, J.T., Ribera, J.M., Oriol, A. i cols. Favorable impact of virological responseto highly active antiretroviral therapy on survival in patients with AIDSrelatednon-Hodgkin’s lymphoma. Leuk Lymphoma 2002 (en premsa).– Northfelt, D.W., Dezube, B.J., Thommes, J.A. i cols. Pegylated-liposomal doxorubicinversus doxorubicin, bleomycin and vincristine in the treatment of AIDSrelatedKaposi’s sarcoma: Results of a randomized phase III clinical trial. J ClinOncol 1998; 16: 2445-2451.– Núñez, M., Machuca, A., Soriano, V., Podzamczer, D., González-Lahoz, J.,Caelyx, K.S. Spanish Study Group. Clearance of human herpesvirus type 8 viraemiain HIV-1 -positive patients with Kaposi’s sarcoma treated with liposomaldoxorubicin. AIDS 2000; 114: 913-919.– Ratner, L., Lee, J., Tang, S. i cols. Chemotherapy for human immunodeficiencyvirus-associated non-Hodgkin’s lymphoma in combination with highly active antiretroviraltherapy. J Clin Oncol 2001; 19: 2171-2178.– Re, A., Casari, S., Cattaneo, Ch. i cols. Hodgkin’s disease developing in patientsinfected by human immunodeficiency virus results in clinical features and a prognosissimilar to those in patients with human immunodeficiency virus-related nonHodgkin’s lymphoma. Cancer 2001; 92: 2739-2745.– Ribera, J.M., Navarro, J.T., Oriol i cols. Prognostic impact of highly active antiretroviraltherapy in human immunodeficiency virus-related Hodgkin’s disease.AIDS 2002 (en premsa).– Saville, M.W., Lietzau, J., Pluda, J.M. i cols. Treatment of HIV-associated Kaposi’ssarcoma with paclitaxel. Lancet 1995; 346: 26-28.– Soler, M., de Sanjosé, S., Ribera, J.M., Dal Maso, L., Casabona, J. Epidemiologyof AIDS-associated malignancies. AIDS Rev 2000; 3: 44-51.– Stewart, S., Jablonowski, H., Goebel, F.D. i cols. Randomized comparative trialof pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatmentof AIDS-related Kaposi’s sarcoma. J Clin Oncol 1998; 16: 683-691.– Tirelli, U., Bernardi, D. Impact of HAART on the clinical management of AIDSrelatedcancers. Eur J Cancer 2001; 37: 1320-1324.– Tirelli, U., Spina, M., Gaidano, G., Vaccher, E., Franceschi, S., Carbone, A.Epidemiological, biological and clinical features of HIV-related lymphomas in theera of highly active antiretroviral therapy. AIDS 2000; 14: 1675-1688.127